These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1756496)

  • 1. Molecular cytogenetic analysis of a medulloblastoma with isochromosome 17 and double minutes.
    Sawyer JR; Swanson CM; Roloson GJ; Longee DC; Boop FA; Chadduck WM
    Cancer Genet Cytogenet; 1991 Dec; 57(2):181-6. PubMed ID: 1756496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A der(11)t(8;11) in two medulloblastomas. A possible nonrandom cytogenetic abnormality.
    Callen DF; Cirocco L; Moore L
    Cancer Genet Cytogenet; 1989 Apr; 38(2):255-60. PubMed ID: 2720638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic evaluation of isochromosome 17q in posterior fossa tumors of children and correlation with clinical outcome in medulloblastoma. Detection of a novel chromosomal abnormality.
    DeChiara C; Borghese A; Fiorillo A; Genesio R; Conti A; D'Amore R; Pettinato G; Varone A; Maggi G
    Childs Nerv Syst; 2002 Aug; 18(8):380-4. PubMed ID: 12192498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-cell medulloblastomas. A distinct variant with highly aggressive behavior.
    Giangaspero F; Rigobello L; Badiali M; Loda M; Andreini L; Basso G; Zorzi F; Montaldi A
    Am J Surg Pathol; 1992 Jul; 16(7):687-93. PubMed ID: 1530108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent gain of 17q and the MYC oncogene in a medullomyoblastoma.
    Lindberg E; Persson A; Øra I; Mertens F; Englund E; Gisselsson D
    Neuropathology; 2007 Dec; 27(6):556-60. PubMed ID: 18021376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic abnormalities in a disseminated medulloblastoma.
    Stuart AG; Pearson AD; Emslie J; Lennard A; Davison EV; Perry RH; Crawford PJ
    Med Pediatr Oncol; 1993; 21(4):295-8. PubMed ID: 8469226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of chromosome 17 abnormalities in medulloblastomas.
    Aldosari N; Rasheed BK; McLendon RE; Friedman HS; Bigner DD; Bigner SH
    Acta Neuropathol; 2000 Apr; 99(4):345-51. PubMed ID: 10787031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive molecular cytogenetic investigation of chromosomal abnormalities in human medulloblastoma cell lines and xenograft.
    Aldosari N; Wiltshire RN; Dutra A; Schrock E; McLendon RE; Friedman HS; Bigner DD; Bigner SH
    Neuro Oncol; 2002 Apr; 4(2):75-85. PubMed ID: 11916498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomic hybridization of medulloblastomas and clinical relevance: eleven new cases and a review of the literature.
    Gilhuis HJ; Anderl KL; Boerman RH; Jeuken JM; James CD; Raffel C; Scheithauer BW; Jenkins RB
    Clin Neurol Neurosurg; 2000 Dec; 102(4):203-209. PubMed ID: 11154805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cytogenetic analysis of a cerebellar primitive neuroectodermal tumor with prominent neuronal differentiation: detection of MYCN amplification by differential polymerase chain reaction and Southern blot analysis.
    Jay V; Squire J; Zielenska M; Gerrie B; Humphreys R
    Pediatr Pathol Lab Med; 1995; 15(5):733-44. PubMed ID: 8597859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple genomic alterations including N-myc amplification in a primary large cell medulloblastoma.
    Reardon DA; Jenkins JJ; Sublett JE; Burger PC; Kun LK
    Pediatr Neurosurg; 2000 Apr; 32(4):187-91. PubMed ID: 10940769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of medulloblastoma in children under age of three years.
    Ryzhova MV; Zheludkova OG; Kumirova ÉV; Shishkina LV; Panina TN; Gorelyshev SK; Khukhlaeva EA; Mazerkina NA; Matuev KB; Medvedeva OA; Tarasova EM; Kholodov BV; Kapitul'skaia OIu
    Zh Vopr Neirokhir Im N N Burdenko; 2013; 77(1):3-10; discussion 11. PubMed ID: 23659115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.
    Leonard JR; Cai DX; Rivet DJ; Kaufman BA; Park TS; Levy BK; Perry A
    J Neurosurg; 2001 Jul; 95(1):82-8. PubMed ID: 11453402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isochromosome 17q, MYC amplification and large cell/anaplastic phenotype in a case of medullomyoblastoma with extracranial metastases.
    Wright KD; von der Embse K; Coleman J; Patay Z; Ellison DW; Gajjar A
    Pediatr Blood Cancer; 2012 Sep; 59(3):561-4. PubMed ID: 22147345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients.
    Lamont JM; McManamy CS; Pearson AD; Clifford SC; Ellison DW
    Clin Cancer Res; 2004 Aug; 10(16):5482-93. PubMed ID: 15328187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci.
    Pfister S; Remke M; Benner A; Mendrzyk F; Toedt G; Felsberg J; Wittmann A; Devens F; Gerber NU; Joos S; Kulozik A; Reifenberger G; Rutkowski S; Wiestler OD; Radlwimmer B; Scheurlen W; Lichter P; Korshunov A
    J Clin Oncol; 2009 Apr; 27(10):1627-36. PubMed ID: 19255330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive medulloblastoma with high-level N-myc amplification.
    Tomlinson FH; Jenkins RB; Scheithauer BW; Keelan PA; Ritland S; Parisi JE; Cunningham J; Olsen KD
    Mayo Clin Proc; 1994 Apr; 69(4):359-65. PubMed ID: 8170180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement.
    Bien-Willner GA; López-Terrada D; Bhattacharjee MB; Patel KU; Stankiewicz P; Lupski JR; Pfeifer JD; Perry A
    Neuro Oncol; 2012 Jul; 14(7):831-40. PubMed ID: 22573308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients.
    Pan E; Pellarin M; Holmes E; Smirnov I; Misra A; Eberhart CG; Burger PC; Biegel JA; Feuerstein BG
    Clin Cancer Res; 2005 Jul; 11(13):4733-40. PubMed ID: 16000568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivative (22)t(3;22)(q12;p11.1) in desmoplastic medulloblastoma.
    Manor E; Bodner L; Kachko P; Kapelushnik J
    Cancer Genet Cytogenet; 2010 Jan; 196(2):175-8. PubMed ID: 20082855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.